C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis

Transfusion

Volumn 49, Issue 9, 2009, Pages 1987-1995

  Kreuz, Wolfhart ^a   Martinez Saguer, Inmaculada ^a   Aygören Pürsün, Emel ^a   Rusicke, Eva ^a   Heller, Christine ^a   Klingebiel, Thomas ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; DANAZOL;

ADULT; ALOPECIA; AMENORRHEA; AMINOTRANSFERASE BLOOD LEVEL; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; FEMALE; HEADACHE; HEART INFARCTION; HOT FLUSH; HUMAN; HYPRTENSION; INDIVIDUAL REPLACEMENT THERAPY; INJECTION SITE ERYTHEMA; LARYNX EDEMA; LIVER ADENOMA; MALE; MORTALITY; QUALITY OF LIFE; SIDE EFFECT; SUBCUTANEOUS TISSUE; SUBSTITUTION THERAPY; VERTIGO; VIRILIZATION; VOICE CHANGE; WEIGHT GAIN;

ADULT; ANGIOEDEMA, HEREDITARY; COMPLEMENT C1 INHIBITOR PROTEIN; COMPLEMENT INACTIVATING AGENTS; DANAZOL; DRUG RESISTANCE; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 69249189438     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02230.x     Document Type: Article

References (31)

1. Donaldson VH, Evans RR. A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C' 1-esterase. Am J Med 1963 35 : 37 44.
2. Bernstein IL. Hereditary angioedema: a current state-of-the-art review, II: historical perspective of non-histamine-induced angioedema. Ann Allergy Asthma Immunol 2008 100 : S2 6.
3. Zuraw BL. Clinical practice. Hereditary angioedema. N Engl J Med 2008 359 : 1027 36.
4. Agostoni A, Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore) 1992 71 : 206 15.
5. Nzeako UC, Frigas E, Tremaine WJ. Hereditary angioedema: a broad review for clinicians. Arch Intern Med 2001 161 : 2417 29.
6. Bork K, Siedlecki K, Bosch S, Schopf RE, Kreuz W. Asphyxiation by laryngeal edema in patients with hereditary angioedema. Mayo Clin Proc 2000 75 : 349 54.
7. Cicardi M, Bergamaschini L, Marasini B, Boccassini G, Tucci A, Agostoni A. Hereditary angioedema: an appraisal of 104 cases. Am J Med Sci 1982 284 : 2 9.
8. Pickering RJ, Good RA, Kelly JR, Gewurz H. Replacement therapy in hereditary angioedema. Successful treatment of two patients with fresh frozen plasma. Lancet 1969 1 : 326 30.
9. Bork K. Pasteurized C1 inhibitor concentrate in hereditary angioedema: pharmacology, safety, efficacy and future directions. Expert Rev Clin Immunol 2008 4 : 13 20.
10. Bork K, Barnstedt SE. Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. Arch Intern Med 2001 161 : 714 8.
11. Longhurst HJ. Emergency treatment of acute attacks in hereditary angioedema due to C1 inhibitor deficiency: what is the evidence? Int J Clin Pract 2005 59 : 594 9.
12. Bowen T, Cicardi M, Bork K, Zuraw B, Frank M, Ritchie B, Farkas H, Varga L, Zingale LC, Binkley K, Wagner E, Adomaitis P, Brosz K, Burnham J, Warrington R, Kalicinsky C, Mace S, McCusker C, Schellenberg R, Celeste L, Hebert J, Valentine K, Poon MC, Serushago B, Neurath D, Yang W, Lacuesta G, Issekutz A, Hamed A, Kamra P, Dean J, Kanani A, Stark D, Rivard GE, Leith E, Tsai E, Waserman S, Keith PK, Page D, Marchesin S, Longhurst HJ, Kreuz W, Rusicke E, Martinez-Saguer I, Aygoren-Pursun E, Harmat G, Fust G, Li H, Bouillet L, Caballero T, Moldovan D, Spath PJ, Smith-Foltz S, Nagy I, Nielsen EW, Bucher C, Nordenfelt P, Xiang ZY. Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. Ann Allergy Asthma Immunol 2008 100 : S30 40.
13. Cicardi M, Zingale LC, Zanichelli A, Deliliers DL, Caccia S. The use of plasma-derived C1 inhibitor in the treatment of hereditary angioedema. Expert Opin Pharmacother 2007 8 : 3173 81.
14. Gelfand JA, Sherins RJ, Alling DW, Frank MM. Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. N Engl J Med 1976 295 : 1444 8.
15. Sanofi-Aventis. Danol® summary of product characteristics [monograph on the internet]. Surrey : Sanofi-Aventis 2006. Available from: http://emc.medicines.org.uk/
16. Spooner JB. Classification of side-effects to danazol therapy. J Int Med Res 1977 5 Suppl. 3 : 15 7.
17. Cicardi M, Castelli R, Zingale LC, Agostoni A. Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients. J Allergy Clin Immunol 1997 99 : 194 6.
18. Hosea SW, Santaella ML, Brown EJ, Berger M, Katusha K, Frank MM. Long-term therapy of hereditary angioedema with danazol. Ann Intern Med 1980 93 : 809 12.
19. Bork K, Bygum A, Hardt J. Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients. Ann Allergy Asthma Immunol 2008 100 : 153 61.
20. Frank MM, Sergent JS, Kane MA, Alling DW. Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study. N Engl J Med 1972 286 : 808 12.
21. Kreuz W, Escuriola-Ettingshausen C, Funk M, Schmidt H, Kornhuber B. When should prophylactic treatment in patients with haemophilia A and B start? - The German experience. Haemophilia 1998 4 : 413 7.
22. Nadler S, Hidalgo J, Bloch T. Prediction of blood volume in normal human adults. Surg 1962 51 : 224 32.
23. Tait RC, Chibnall JT, Krause S. The Pain Disability Index: psychometric properties. Pain 1990 40 : 171 82.
24. Boyer JL, Preisig R, Zbinden G, de Kretser DM, Wang C, Paulsen CA. Guidelines for assessment of potential hepatotoxic effects of synthetic androgens, anabolic agents and progestagens in their use in males as antifertility agents. Contraception 1976 13 : 461 8.
25. Zurlo JJ, Frank MM. The long-term safety of danazol in women with hereditary angioedema. Fertil Steril 1990 54 : 64 72.
26. Andriole GL, Brickman C, Lack EE, Sesterhenn IA, Javadpour N, Linehan WM, Frank MM. Danazol-induced cystitis: an undescribed source of hematuria in patients with hereditary angioneurotic edema. J Urol 1986 135 : 44 6.
27. Bork K, Schneiders V. Danazol-induced hepatocellular adenoma in patients with hereditary angio-oedema. J Hepatol 2002 36 : 707 9.
28. Falk H, Thomas LB, Popper H, Ishak KG. Hepatic angiosarcoma associated with androgenic-anabolic steroids. Lancet 1979 2 : 1120 3.
29. Weill BJ, Menkes CJ, Cormier C, Louvel A, Dougados M, Houssin D. Hepatocellular carcinoma after danazol therapy. J Rheumatol 1988 15 : 1447 9.
30. Levi M, Choi G, Picavet C, Hack CE. Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency. J Allergy Clin Immunol 2006 117 : 904 8.
31. Kunschak M, Engl W, Maritsch F, Rosen FS, Eder G, Zerlauth G, Schwarz HP. A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema. Transfusion 1998 38 : 540 9.